179900-21-1

Basic information

• Product Name: 4-(3-Fluoro-2-nitrophenyl)morpholine
• Synonyms: 4-(3-Fluoro-2-nitrophenyl)morpholine;6-Fluoro-2-morpholinonitrobenzene
• CAS NO: 179900-21-1
• Molecular Formula: C₁₀H₁₁FN₂O₃
• Molecular Weight: 226.21
• Mol File: 179900-21-1.mol

Chemical Properties

• Boiling Point: 381.5±42.0 °C(Predicted)
• Appearance: /
• Density: 1.340±0.06 g/cm3(Predicted)
• PKA: 1.68±0.40(Predicted)
• CAS DataBase Reference: 4-(3-Fluoro-2-nitrophenyl)morpholine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-Fluoro-2-nitrophenyl)morpholine(179900-21-1)
• EPA Substance Registry System: 4-(3-Fluoro-2-nitrophenyl)morpholine(179900-21-1)

Safety Data

• Hazardous Substances Data: 179900-21-1(Hazardous Substances Data)

Upstream product

• 110-91-8 morpholine 
• 19064-24-5 2,6-difluoro-1-nitrobenzene 
• 886762-70-5 2?bromo?6?fluoronitrobenzene 

Downstream Products

• 74628-19-6 3-(morpholin-4-yl)-2-nitroaniline 

Relevant articles and documents

Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like Proteins

The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.

CARBAZOLE AND CARBOLINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH AMYLOID OR AMYOLID-LIKE PROTEINS

The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.

BENZIMIDAZOLE QUINOLINONES AND USES THEREOF

Methods of inhibiting various enzymes and treating various conditions are provided that include administering to a subject a compound of Structure I or IB, a pharmaceutically acceptable salt thereof, a tautomer thereof, or a pharmaceutically acceptable salt of the tautomer. Compounds having the Structure I and IB have the following structures and have the variables described herein. Such compounds may be used to prepare medicaments for use in inhibiting various enzymes and for use in treating conditions mediated by such enzymes.